ID
int64 1
9.11k
| age
float64 18
102
| death
int64 0
1
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| d.time
int64 3
2.03k
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1,301 | 73.99896 | 1 | female | 0 | 5 | 415 | COPD | COPD/CHF/Cirrhosis | 3 | 12 | under $11k | 0 | 15,322 | 6,225.7891 | 6,328.29688 | 17 | white | 22.699219 | 23 | 0.780884 | 0.649902 | 1 | 0 | 0 | no | 0.5 | 0.5 | dnr after sadm | 1 | 50 | 30.699219 | 55 | 36 | 35.5 | null | null | 1.299805 | 2.299805 | 122 | null | 105 | 40 | 209 | null | null | no(M2 and SIP pres) | 3.094727 |
1,302 | 57.43997 | 1 | female | 0 | 12 | 91 | Colon Cancer | Cancer | 1 | 12 | $25-$50k | 0 | 50,645 | 22,831.8906 | 24,215.5781 | 25.5 | white | 35 | 32 | 0.448975 | 0.13797 | 1 | 0 | 0 | metastatic | 0.4 | 0.2 | no dnr | 12 | 78 | 11.099609 | 70 | 20 | 37.89844 | 223.3125 | 2.299805 | null | 1.599854 | 137 | 7.419922 | 102 | 41 | 2,540 | 0 | 0 | adl>=4 (>=5 if sur) | 0 |
1,303 | 70.45599 | 1 | female | 1 | 4 | 4 | Coma | Coma | 1 | 11 | >$50k | 44 | 52,477 | 15,849.2422 | 21,040.875 | 34 | black | 25.699219 | 45 | 0.313965 | 0.241974 | 5 | 0 | 0 | no | 0.2 | 0.15 | dnr after sadm | 4 | 110 | 15.099609 | 155 | 44 | 36.59375 | 680 | 2.599609 | 0.899902 | 1.599854 | 131 | 7.459961 | 114 | 47 | 15 | null | 0 | <2 mo. follow-up | 0 |
1,304 | 63.88199 | 1 | male | 1 | 8 | 8 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | null | null | 41 | 178,201 | 23,809.0938 | 25,333.0781 | 47 | white | 31.097656 | 52 | 0.394958 | 0.27594 | 15 | 0 | 0 | no | 0.5 | 0.5 | no dnr | 8 | 70 | 7.399414 | 45 | 28 | 36.09375 | null | null | null | 1.5 | 139 | null | 90 | 28 | 1,175 | null | null | <2 mo. follow-up | 3.230957 |
1,305 | 46.00699 | 1 | male | 1 | 4 | 4 | MOSF w/Malig | ARF/MOSF | 3 | 14 | $25-$50k | 44 | 135,769 | 16,093.7578 | 16,401.4688 | 49 | white | 33.296875 | 68 | 0.16098 | 0.079987 | 19 | 0 | 0 | yes | 0.05 | 0.05 | dnr after sadm | 2 | 45 | 22.699219 | 125 | 28 | 35.19531 | 168 | null | 4.5 | 3.699707 | 143 | 7.259766 | 180 | 55 | 10 | null | null | <2 mo. follow-up | 3.269531 |
1,306 | 63.07999 | 0 | female | 0 | 4 | 649 | CHF | COPD/CHF/Cirrhosis | 3 | null | null | 0 | 11,751 | 5,963.4883 | 4,836.85938 | 19 | white | 16.597656 | 18 | 0.896973 | 0.827881 | 1 | 1 | 0 | no | 0.9 | 0.8 | no dnr | 4 | 73 | 11.099609 | 102 | 26 | 36.19531 | null | null | null | 0.899902 | 131 | null | 346 | 12 | 3,150 | null | null | null | 2.264648 |
1,307 | 64.34796 | 0 | male | 0 | 6 | 649 | Cirrhosis | COPD/CHF/Cirrhosis | 1 | 14 | null | 0 | 7,934 | 3,826.3965 | 2,599.76953 | 4 | hispanic | 21.898438 | 34 | 0.73291 | 0.581909 | 1 | 0 | 0 | no | null | null | no dnr | 6 | 63 | 3.699707 | 136 | 32 | 36.19531 | null | 2.5 | null | 0.799927 | 133 | null | null | 15 | 1,250 | 2 | null | null | 1.838867 |
1,308 | 52.02698 | 1 | male | 0 | 19 | 201 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | 14 | >$50k | 26 | 287,368 | 42,209.5 | 43,078.5938 | 34 | white | 39.195313 | 84 | 0.312988 | 0.199982 | 17 | 0 | 0 | no | 0.5 | 0.5 | no dnr | 19 | 112 | 14.398438 | 140 | 34 | 39.19531 | 182.5 | null | null | 1.299805 | 135 | 7.529297 | 279 | 36 | 1,770 | null | 0 | no(M2 and SIP pres) | 0 |
1,309 | 59.75598 | 0 | male | 0 | 6 | 647 | Cirrhosis | COPD/CHF/Cirrhosis | 4 | 14 | >$50k | 0 | 29,213 | 14,474.2109 | 11,215.9141 | 8 | white | 19.296875 | 20 | 0.802979 | 0.681885 | 1 | 0 | 0 | no | 0.6 | 0.4 | no dnr | 6 | 113 | 12.599609 | 135 | 49 | 39.5 | 130 | null | null | 1.399902 | 143 | 7.479492 | 148 | 24 | 1,710 | null | null | no(M2 and SIP pres) | 2.734863 |
1,310 | 72.80194 | 0 | male | 0 | 20 | 643 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 16 | >$50k | 0 | 226,908 | 45,777.5625 | 44,422.8125 | 35.333313 | white | 25.699219 | 43 | 0.689941 | 0.5979 | 8 | 1 | 0 | no | 0.75 | 0.75 | no dnr | 20 | 57 | 6.099609 | 155 | 25 | 37.39844 | 118.65625 | null | 1.799805 | 0.899902 | 131 | 7.419922 | null | 21 | 695 | null | null | null | 2.445313 |
1,311 | 73.68695 | 1 | male | 0 | 7 | 11 | Lung Cancer | Cancer | 2 | null | null | 0 | 14,124 | 7,226.3828 | 6,628.61719 | 9 | white | 24.5 | 24 | 0.500977 | 0.179993 | 1 | 0 | 0 | metastatic | 0.01 | 0 | dnr after sadm | 2 | 63 | null | 65 | 20 | 36.29688 | null | null | null | 1 | 133 | null | 462 | 18 | 3,600 | null | null | <2 mo. follow-up | 3.989258 |
1,312 | 70.508 | 1 | female | 0 | 7 | 45 | MOSF w/Malig | ARF/MOSF | 1 | null | null | 0 | 42,089 | 9,950.7969 | 10,467.1562 | 13.5 | white | 20.296875 | 20 | 0.720947 | 0.635986 | 4 | 0 | 0 | yes | null | null | dnr before sadm | -1 | 75 | 9.898438 | 74 | 20 | 36.39844 | null | null | 8.5 | null | 134 | null | null | null | 1,430 | null | null | <2 mo. follow-up | 1.982422 |
1,313 | 55.50198 | 0 | male | 0 | 44 | 639 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | $25-$50k | 0 | 338,671 | 150,056.5 | 157,278.375 | 40.75 | white | 29.898438 | 46 | 0.750977 | 0.671997 | 1 | 0 | 0 | no | 0 | 0 | no dnr | 44 | 58 | 22.296875 | 115 | 44 | 38.09375 | 330 | null | 25.597656 | 3 | 142 | 7.5 | 211 | 136 | 4,520 | null | 0 | no(M2 and SIP pres) | 0 |
1,314 | 63.94299 | 0 | female | 0 | 34 | 637 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 12 | under $11k | 26 | 252,684 | 66,653.875 | 63,813.4062 | 34.5 | hispanic | 28.796875 | 45 | 0.585938 | 0.47699 | 4 | 0 | 0 | no | 0.9 | 0.8 | no dnr | 34 | 67 | 9.798828 | 96 | 22 | 38.19531 | null | null | 3.399902 | 0.699951 | 133 | null | 181 | 8 | 2,625 | 1 | null | null | 1.166748 |
1,315 | 47.47998 | 0 | female | 0 | 30 | 636 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 14 | $25-$50k | 0 | 339,838 | 66,693.75 | 62,851.2812 | 27.5 | white | 27.898438 | 39 | 0.747925 | 0.667969 | 16 | 0 | 0 | no | 0.9 | 0.9 | no dnr | 30 | 62 | 12.5 | 135 | 37 | 38.59375 | 347.5 | null | null | 1.5 | 152 | 7.589844 | 304 | 33 | 2,712 | 0 | null | null | 0.494751 |
1,316 | 50.51099 | 0 | female | 0 | 25 | 636 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 15 | $25-$50k | 9 | 131,648 | 43,402.2188 | 27,873.1094 | 23.5 | white | 23.796875 | 24 | 0.806885 | 0.74292 | 4 | 0 | 0 | no | 0.95 | 0.8 | no dnr | 25 | 70 | 14.798828 | 82 | 22 | 36.39844 | null | 3.099609 | 4.299805 | 0.799927 | 136 | null | 113 | 15 | 800 | 0 | null | null | 0.494751 |
1,317 | 66.771 | 1 | female | 0 | 9 | 487 | Colon Cancer | Cancer | 1 | 12 | null | 0 | 18,716 | 8,287.7969 | 7,270.66797 | 10.5 | white | 14.5 | 16 | 0.845947 | 0.659912 | 1 | 0 | 0 | metastatic | 1 | 0.8 | no dnr | 9 | 82 | 9.699219 | 96 | 24 | 38 | null | null | null | 2.699707 | 138 | null | null | 37 | 4,250 | 0 | null | null | 0.494751 |
1,318 | 51.85199 | 1 | male | 0 | 15 | 57 | MOSF w/Malig | ARF/MOSF | 1 | 14 | $25-$50k | 0 | 54,700 | 25,739.7344 | 31,346.2969 | 11.333328 | white | 28.199219 | 17 | 0.549927 | 0.436951 | 1 | 0 | 0 | metastatic | 0.7 | 0.5 | dnr after sadm | 14 | 52 | 17.898438 | 105 | 26 | 38.69531 | 145.6875 | 2.599609 | 0.899902 | 1.299805 | 136 | 7.519531 | 164 | 23 | 3,800 | 0 | 0 | <2 mo. follow-up | 0 |
1,319 | 58.63397 | 1 | female | 0 | 17 | 572 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | null | 0 | 145,518 | 34,237.9688 | 36,742.8438 | 25.666656 | hispanic | 33.296875 | 53 | 0.496948 | 0.378967 | 13 | 0 | 0 | yes | 0.75 | 0.75 | no dnr | 17 | 65 | 10.398438 | 125 | 24 | 36.59375 | 186.65625 | 2.599609 | 7.199219 | 1.099854 | 143 | 7.479492 | 345 | 54 | 1,690 | 0 | 0 | null | 0 |
1,320 | 74.41797 | 0 | female | 0 | 8 | 634 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 15 | >$50k | 26 | 243,036 | 22,826.3125 | 23,285.8125 | 48 | white | 25 | 50 | 0.494995 | 0.376953 | 14 | 0 | 0 | yes | 0.8 | 0.7 | no dnr | 8 | 122 | 1.599854 | 65 | 24 | 38.09375 | 248.96875 | null | 10.199219 | 0.799927 | 137 | 7.449219 | 152 | 32 | 5,290 | null | null | null | 2.758301 |
1,321 | 60.01398 | 0 | male | 0 | 15 | 634 | Colon Cancer | Cancer | 1 | 16 | >$50k | 0 | 54,862 | 23,652.125 | 28,416.7656 | 12 | white | 15.398438 | 20 | 0.844971 | 0.659912 | 1 | 0 | 0 | metastatic | 0.9 | 0.7 | no dnr | 15 | 99 | 40.796875 | 120 | 24 | 37.89844 | 254.65625 | null | 4.099609 | 0.799927 | 139 | 7.529297 | 107 | 8 | 3,320 | null | null | no(M2 and SIP pres) | 2.57666 |
1,322 | 34.53799 | 1 | female | 1 | 28 | 28 | Cirrhosis | COPD/CHF/Cirrhosis | 2 | 12 | >$50k | 0 | 318,788 | 148,268.875 | 152,781.125 | 28.75 | hispanic | 17.296875 | 22 | 0.915894 | 0.85791 | 1 | 0 | 0 | no | 0.99 | 0.99 | no dnr | 28 | 72 | 14.099609 | 78 | 22 | 38 | null | null | null | 0.799927 | 138 | null | null | 4 | 1,150 | null | 6 | <2 mo. follow-up | 6 |
1,323 | 79.25494 | 1 | male | 0 | 33 | 411 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 14 | under $11k | 0 | 194,939 | 77,189.125 | 74,435.875 | 26.5 | white | 20.898438 | 17 | 0.777954 | 0.705933 | 3 | 0 | 1 | no | 0.9 | 0.9 | dnr after sadm | 8 | 100 | 15.898438 | 106 | 14 | 36.39844 | 90 | null | 0.5 | 1 | 135 | 7.459961 | 177 | 15 | 1,200 | null | null | null | 4.164063 |
1,324 | 59.409 | 0 | male | 0 | 36 | 628 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | null | null | 0 | 618,719 | 256,636.625 | 225,256.125 | 49.5 | white | 31.898438 | 58 | 0.674927 | 0.579956 | 2 | 0 | 0 | no | null | null | no dnr | 36 | 62 | 31.699219 | 115 | 10 | 35.79688 | 168 | null | 2.699707 | 2.599609 | 138 | 7.419922 | 96 | 29 | 3,240 | null | null | null | 2.714844 |
1,325 | 46.31598 | 1 | female | 0 | 11 | 404 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 14 | under $11k | 0 | 123,254 | 43,014.375 | 47,108.5312 | 48.5 | black | 27.296875 | 46 | 0.809937 | 0.746948 | 2 | 0 | 0 | no | 0.95 | 0.95 | no dnr | 11 | 67 | 28.398438 | 115 | 40 | 38.29688 | 360 | null | null | 1.899902 | 137 | 7.439453 | 207 | 84 | 2,360 | null | null | null | 2.416504 |
1,326 | 73.10895 | 1 | female | 1 | 23 | 23 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | null | null | 41 | 258,088 | 88,220.75 | 105,923.562 | 47.666657 | asian | 44.5 | 63 | 0.058998 | 0.019997 | 4 | 1 | 0 | no | 0.4 | 0.25 | no dnr | 23 | 78 | 11 | 116 | 24 | 38.39844 | null | 3.199707 | 1.699951 | 1.099854 | 138 | null | 142 | 8 | 850 | null | null | <2 mo. follow-up | 3.595215 |
1,327 | 72.28699 | 1 | male | 1 | 4 | 4 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 11 | null | 41 | 235,312 | 20,672.3125 | 21,320.125 | 51 | white | 36.796875 | 83 | 0.178986 | 0.091995 | 14 | 0 | 0 | no | null | null | dnr after sadm | 3 | 69 | 4.899414 | 72 | 14 | 37.79688 | null | 2.899902 | 3.399902 | 0.599976 | 135 | null | 93 | 6 | 1,950 | null | 0 | <2 mo. follow-up | 0 |
1,328 | 51.72897 | 0 | female | 0 | 6 | 626 | CHF | COPD/CHF/Cirrhosis | 2 | 12 | under $11k | 0 | 11,742 | 6,274.8945 | 5,124.20703 | 18 | white | 16.5 | 20 | 0.919922 | 0.863892 | 1 | 0 | 0 | no | 0.9 | 0.85 | no dnr | 6 | 107 | 11.099609 | 55 | 10 | 36.39844 | 365 | 2.299805 | 1.099854 | 0.799927 | 132 | 7.459961 | 148 | 14 | 2,655 | 0 | null | no(M2 and SIP pres) | 0.494751 |
1,329 | 52.89499 | 0 | female | 0 | 15 | 625 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 18 | >$50k | 100 | 110,588 | 39,434.4688 | 48,186.0938 | 38 | white | 31 | 58 | 0.286987 | 0.176971 | 1 | 0 | 0 | no | 0.1 | 0.1 | no dnr | 15 | 55 | 11.099609 | 105 | 10 | 38.5 | 250 | 3 | 4.5 | 3.599609 | 148 | 7.539062 | 212 | 57 | 3,988 | null | 0 | no(M2 and SIP pres) | 0 |
1,330 | 44.31799 | 1 | male | 0 | 27 | 132 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | 11 | $11-$25k | 0 | 500,747 | 45,473.6562 | 39,775.9688 | 28.75 | white | 26.296875 | 48 | 0.781982 | 0.710938 | 23 | 0 | 0 | no | 0.9 | 0.8 | no dnr | 27 | 72 | 27 | 145 | 40 | 38.79688 | 202 | null | 1.199951 | 0.599976 | 136 | 7.389648 | null | 10 | 4,580 | null | 2 | adl>=4 (>=5 if sur) | 2 |
1,331 | 75.87695 | 1 | male | 0 | 35 | 406 | COPD | COPD/CHF/Cirrhosis | 1 | null | null | 0 | 247,610 | 92,767.625 | 104,459.875 | 34.25 | white | 25.398438 | 55 | 0.718994 | 0.562988 | 1 | 0 | 0 | no | 0.6 | 0.5 | dnr after sadm | 12 | 35 | 17.296875 | 185 | 10 | 37.69531 | 245 | null | null | 3.899902 | 133 | 7.369141 | 186 | 46 | 3,790 | null | null | null | 2.962402 |
1,332 | 69.46198 | 0 | male | 0 | 16 | 622 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 15 | $25-$50k | 0 | 156,624 | 50,043.9688 | 50,702.4062 | 35.666657 | white | 36.796875 | 63 | 0.471985 | 0.352966 | 3 | 0 | 0 | no | 0.5 | 0.5 | no dnr | 16 | 156 | 112.1875 | 135 | 35 | 38.29688 | 100 | null | null | 3.5 | 139 | 7.279297 | null | 73 | 0 | null | null | no(M2 and SIP pres) | 2.757813 |
1,333 | 42.44998 | 1 | female | 0 | 3 | 38 | Lung Cancer | Cancer | 1 | 17 | >$50k | 0 | 10,409 | 4,667.8398 | 5,180.37891 | 12 | white | 20.5 | 22 | 0.691895 | 0.401978 | 1 | 0 | 0 | metastatic | 0.6 | 0.2 | no dnr | 3 | 70 | 7 | 100 | 26 | 35.89844 | null | 4 | 0.899902 | 1.199951 | 136 | null | 104 | 13 | 2,400 | null | null | <2 mo. follow-up | 2.447754 |
1,334 | 66.98999 | 1 | female | 0 | 85 | 385 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | under $11k | 26 | 501,448 | null | null | 44.5 | white | 23 | 33 | 0.741943 | 0.660889 | 1 | 1 | 0 | no | 0.6 | 0.5 | no dnr | 85 | 67 | 35.695313 | 130 | 28 | 38.59375 | 345.6875 | 3.199707 | 2.399902 | 4.5 | 134 | 7.519531 | null | 166 | 5,435 | null | null | null | 2.827148 |
1,335 | 63.36798 | 0 | male | 0 | 33 | 618 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 37 | 294,992 | 85,296 | 80,205.5625 | 40.5 | white | 29.5 | 48 | 0.507935 | 0.390991 | 5 | 0 | 0 | no | 0.8 | 0.8 | no dnr | 33 | 115 | 11.199219 | 55 | 26 | 36.39844 | null | 2.399902 | 10.298828 | 1 | 138 | null | 140 | 49 | 2,960 | null | 0 | no(M2 and SIP pres) | 0 |
1,336 | 61.741 | 1 | male | 1 | 10 | 10 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | 14 | $25-$50k | 37 | 337,918 | 41,536.5 | 47,599.1562 | 49 | white | 41.59375 | 43 | 0.14798 | 0.070999 | 11 | 1 | 0 | no | 0.75 | 0.75 | no dnr | 10 | 63 | 11.798828 | 155 | 25 | 38 | 173 | null | null | 1.299805 | 134 | 7.289062 | 188 | 24 | 3,185 | null | null | <2 mo. follow-up | 3.759766 |
1,337 | 68.23297 | 1 | male | 0 | 16 | 196 | MOSF w/Malig | ARF/MOSF | 1 | 16 | >$50k | 0 | 110,698 | 44,902.375 | 38,490.7188 | 31.666656 | white | 24.796875 | 51 | 0.675903 | 0.580933 | 1 | 0 | 0 | yes | 0.5 | 0.125 | no dnr | 16 | 67 | 5.599609 | 125 | 23 | 38 | 107.04688 | 3.899902 | 4.199219 | 3.299805 | 139 | 7.399414 | 231 | 42 | 990 | null | 2 | adl>=4 (>=5 if sur) | 2 |
1,338 | 70.04199 | 0 | male | 0 | 8 | 615 | Colon Cancer | Cancer | 1 | 12 | $11-$25k | 0 | 22,080 | 9,438.75 | 11,645.9297 | 11 | white | 13 | 9 | 0.856934 | 0.681885 | 1 | 0 | 0 | metastatic | 0.9 | 0.8 | no dnr | 8 | 115 | 11.699219 | 112 | 24 | 36.79688 | null | null | null | 0.699951 | 138 | null | null | 7 | 570 | 0 | 0 | no(M2 and SIP pres) | 0 |
1,339 | 71.36798 | 1 | male | 1 | 9 | 9 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | null | null | 9 | 86,494 | 31,125.2344 | 32,541.3125 | 31.5 | white | 37.695313 | 57 | 0.431946 | 0.312988 | 1 | 0 | 0 | no | 0.2 | 0.9 | dnr after sadm | 9 | 70 | 7 | 110 | 14 | 36.5 | 373.3125 | null | 1.699951 | 2.099609 | 137 | 7.329102 | 69 | 110 | 2,210 | null | null | <2 mo. follow-up | 2.898926 |
1,340 | 43.25497 | 0 | male | 0 | 11 | 614 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 15 | $25-$50k | 26 | 186,516 | 22,284.4531 | 21,458.2969 | 21 | white | 30.199219 | 42 | 0.640991 | 0.539917 | 9 | 0 | 0 | no | 0.8 | 0.8 | no dnr | 11 | 62 | 14.699219 | 125 | 26 | 38.59375 | 173.3125 | null | 2.299805 | 1.899902 | 145 | 7.429688 | 241 | 38 | 1,926 | 1 | null | no(M2 and SIP pres) | 1.166748 |
1,341 | 73.90594 | 1 | male | 0 | 4 | 33 | Colon Cancer | Cancer | 2 | null | null | 26 | 12,433 | 5,055.2578 | 7,972.87891 | 21 | white | 35.195313 | 15 | 0.240997 | 0.029999 | 1 | 0 | 0 | metastatic | 0.3 | 0.5 | dnr after sadm | 3 | 62 | 15.398438 | 75 | 6 | 35.39844 | 87 | 2.399902 | 28.097656 | 1.399902 | 130 | 7.439453 | 145 | 22 | 3,695 | null | null | <2 mo. follow-up | 2.93457 |
1,342 | 59.19498 | 1 | male | 0 | 8 | 85 | CHF | COPD/CHF/Cirrhosis | 4 | null | $11-$25k | 0 | 31,431 | 13,725.5938 | 14,902.5391 | 27.5 | white | 33.796875 | 38 | 0.669922 | 0.496948 | 1 | 1 | 0 | no | 0.6 | 0.3 | no dnr | 8 | 140 | 15.099609 | 110 | 50 | 38 | 193.3125 | null | null | 1.199951 | 142 | 7.549805 | 160 | 22 | 3,355 | 5 | 4 | adl>=4 (>=5 if sur) | 4 |
1,343 | 70.81195 | 1 | female | 1 | 27 | 27 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | 12 | under $11k | 37 | 213,777 | 75,374.125 | 87,726.4375 | 38.5 | white | 21.796875 | 26 | 0.647949 | 0.547974 | 1 | 0 | 0 | yes | 0.8 | 0.65 | dnr after sadm | 7 | 115 | 10.5 | 106 | 24 | 38.5 | null | 3.899902 | 1 | 1 | 134 | null | 82 | 9 | 2,950 | null | 2 | <2 mo. follow-up | 2 |
1,344 | 73.98499 | 0 | female | 0 | 9 | 612 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 10 | $11-$25k | 9 | 140,801 | 19,539.7812 | 16,611.9531 | 26 | black | 17.796875 | 13 | 0.796997 | 0.72998 | 8 | 0 | 0 | no | null | null | no dnr | 9 | 57 | 34.195313 | 110 | 24 | 35.69531 | 165.28125 | 3.099609 | 3 | 3.299805 | 133 | 7.469727 | 70 | 54 | 4,600 | null | 0 | adl>=4 (>=5 if sur) | 0 |
1,345 | 70.41797 | 0 | female | 0 | 8 | 612 | Colon Cancer | Cancer | 1 | 14 | null | 0 | 22,418 | 10,673.7266 | 12,543.1484 | 8 | hispanic | 14.898438 | 17 | 0.834961 | 0.638916 | 1 | 0 | 0 | metastatic | 1 | 0.95 | no dnr | 8 | 71 | 15 | 80 | 24 | 35.79688 | 120 | null | 4.099609 | 1.699951 | 135 | 7.379883 | 131 | 67 | 1,304 | 1 | null | no(M2 and SIP pres) | 1.166748 |
1,346 | 79.93195 | 1 | female | 1 | 22 | 22 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | 18 | under $11k | 26 | 207,417 | 67,940.125 | 75,389.4375 | 36.666657 | white | 17.296875 | 20 | 0.750977 | 0.672974 | 4 | 1 | 0 | no | 0.6 | 0.5 | dnr after sadm | 21 | 84 | 8.398438 | 58 | 24 | 35.79688 | null | 2.199707 | 0.899902 | 0.599976 | 133 | null | null | 10 | null | null | 6 | <2 mo. follow-up | 6 |
1,347 | 66.62299 | 0 | female | 0 | 7 | 602 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 13 | >$50k | 0 | 53,890 | 10,291.6172 | 12,070.4141 | 6.5 | white | 17.898438 | 10 | 0.852905 | 0.80188 | 4 | 0 | 0 | no | 0.9 | 0.9 | no dnr | 7 | 52 | 10.599609 | 100 | 22 | 36.5 | null | 2.899902 | 1.099854 | 1.799805 | 127 | null | 118 | 67 | 2,310 | 0 | 0 | null | 0 |
1,348 | 58.69998 | 1 | female | 1 | 14 | 14 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 16 | null | 44 | 208,373 | 61,822.5625 | 65,557 | 45.666657 | white | 35 | 74 | 0.335999 | 0.220978 | 6 | 0 | 0 | no | 0.85 | 0.85 | dnr after sadm | 13 | 68 | 23.097656 | 125 | 12 | 37.79688 | 395 | null | null | 0.699951 | 136 | 7.40918 | 215 | 10 | 1,950 | null | 1 | <2 mo. follow-up | 1 |
1,349 | 29.26999 | 1 | male | 1 | 9 | 9 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | null | null | 41 | 272,792 | 110,223.438 | 120,070.438 | 45 | hispanic | 28.796875 | 62 | 0.69397 | 0.602905 | 7 | 0 | 0 | no | 0.6 | 0.6 | dnr after sadm | 9 | 105 | 14.599609 | 65 | 24 | 38.5 | null | null | null | 0.799927 | 132 | null | 89 | 17 | 2,230 | null | null | <2 mo. follow-up | 3.072754 |
1,350 | 36.26797 | 0 | female | 0 | 22 | 599 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 21 | >$50k | 41 | 262,040 | 85,402.5625 | 71,938.9375 | 39 | white | 28.898438 | 26 | 0.651978 | 0.552979 | 8 | 0 | 0 | no | 0.95 | 0.95 | no dnr | 22 | 67 | 13.5 | 100 | 24 | 38.19531 | null | 3.599609 | 0.5 | 0.899902 | 136 | null | null | 9 | 1,600 | null | 0 | no(M2 and SIP pres) | 0 |
1,351 | 97.23999 | 1 | male | 0 | 10 | 46 | CHF | COPD/CHF/Cirrhosis | 4 | 12 | null | 9 | 19,291 | 10,616.0938 | 8,190.79688 | 9 | white | 17 | 11 | 0.761963 | 0.622925 | 1 | 0 | 1 | no | 0.8 | 0.06 | no dnr | 10 | 73 | 10.298828 | 83 | 20 | 37.09375 | 252.375 | 3.699707 | 0.5 | 1.699951 | 136 | 7.369141 | 138 | 19 | null | null | 6 | <2 mo. follow-up | 6 |
1,352 | 44.37198 | 0 | male | 0 | 22 | 598 | MOSF w/Malig | ARF/MOSF | 1 | 14 | >$50k | 26 | 174,634 | 49,494.4375 | 42,848.5938 | 26.666656 | white | 29.296875 | 28 | 0.366943 | 0.248993 | 17 | 0 | 0 | yes | 0.6 | 0.5 | no dnr | 22 | 65 | 13.699219 | 80 | 27 | 37.69531 | 300 | null | null | 0.799927 | 135 | 7.419922 | null | 19 | 4,165 | null | 0 | no(M2 and SIP pres) | 0 |
1,353 | 62.06198 | 0 | male | 0 | 13 | 598 | Coma | Coma | 0 | 16 | >$50k | 9 | 105,947 | 42,417.3438 | 43,350.9062 | 43 | white | 25.199219 | 61 | 0.647949 | 0.587891 | 1 | 0 | 0 | no | 0.75 | 0.7 | no dnr | 13 | 117 | 8.199219 | 108 | 22 | 36.59375 | null | null | null | 0.699951 | 139 | null | null | 5 | 2,000 | null | null | no(M2 and SIP pres) | 1.856934 |
1,354 | 57.97699 | 1 | male | 1 | 4 | 4 | MOSF w/Malig | ARF/MOSF | 3 | null | null | 44 | 70,163 | 13,175.4844 | 12,544.7031 | 28 | white | 37.5 | 81 | 0.07399 | 0.026997 | 11 | 0 | 0 | yes | null | null | dnr after sadm | 3 | 113 | 25.398438 | 155 | 60 | 39.69531 | 91.42188 | 1.799805 | 0.699951 | 0.799927 | 135 | 7.349609 | 262 | 14 | 5,101 | null | null | <2 mo. follow-up | 3.311035 |
1,355 | 75.96698 | 0 | male | 0 | 7 | 593 | COPD | COPD/CHF/Cirrhosis | 3 | 0 | $11-$25k | 0 | 21,141 | 8,768.1953 | 7,733.06641 | 16.5 | white | 17.5 | 17 | 0.80188 | 0.680908 | 1 | 0 | 0 | yes | 0.85 | 0.8 | no dnr | 7 | 105 | 6.199219 | 115 | 10 | 38 | 228 | 3 | 8.798828 | 1.599854 | 155 | 7.5 | 259 | 99 | 6,920 | 2 | null | null | 1.838867 |
1,356 | 71.99695 | 1 | female | 0 | 21 | 360 | Coma | Coma | 0 | null | null | 44 | 155,313 | 52,658.3125 | 53,115.3438 | 29.666656 | white | 18.597656 | 28 | 0.516968 | 0.44696 | 4 | 0 | 0 | no | 0.5 | 0.5 | no dnr | 21 | 105 | 15.5 | 135 | 26 | 39 | 340 | null | null | 0.799927 | 125 | 7.529297 | 114 | 16 | 4,950 | null | null | null | 2.020996 |
1,357 | 31.403 | 0 | female | 0 | 14 | 590 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 21 | >$50k | 44 | 84,726 | 31,389.7344 | 35,480.8438 | 25.666656 | white | 35.195313 | 51 | 0.550903 | 0.437988 | 3 | 0 | 0 | no | 0.8 | 0.8 | no dnr | 14 | 99 | 11.898438 | 76 | 24 | 36.39844 | null | null | null | 1.199951 | 133 | null | 131 | 19 | 1,400 | null | null | null | 2.734375 |
1,358 | 59.87097 | 1 | male | 0 | 6 | 381 | Colon Cancer | Cancer | 1 | null | null | 0 | 20,640 | 8,659.2891 | 9,405.875 | 11 | white | 19.5 | 19 | 0.791992 | 0.560913 | 1 | 0 | 0 | metastatic | 0.9 | 0.5 | no dnr | 6 | 102 | 0.049995 | 65 | 24 | 36.39844 | 452 | null | 1.5 | 0.699951 | 130 | 7.489258 | null | 16 | 3,400 | null | null | no(M2 and SIP pres) | 2.047852 |
1,359 | 71.12897 | 1 | female | 0 | 8 | 116 | COPD | COPD/CHF/Cirrhosis | 1 | 13 | $11-$25k | 37 | 57,493 | 14,015.8281 | 13,624.9297 | 16 | white | 26.5 | 34 | 0.530884 | 0.330994 | 5 | 0 | 0 | no | 0.75 | 0.75 | no dnr | 8 | 58 | 14.099609 | 115 | 28 | 38 | 415 | null | 1.299805 | 1.899902 | 135 | 7.40918 | 301 | 30 | 1,640 | null | null | Coma or Intub | 3.345215 |
1,360 | 69.19397 | 0 | male | 0 | 8 | 586 | CHF | COPD/CHF/Cirrhosis | 3 | 12 | null | 0 | 23,046 | 12,267.5391 | 10,595.7656 | 16 | white | 29.199219 | 32 | 0.644897 | 0.464966 | 1 | 0 | 0 | yes | 0.9 | 0.75 | dnr after sadm | 3 | 133 | 19.898438 | 155 | 33 | 37.89844 | 177.53125 | 2.399902 | 18.199219 | 2.199707 | 144 | 7.449219 | null | 85 | 2,665 | 0 | 4 | null | 4 |
1,361 | 64.02197 | 0 | male | 0 | 12 | 586 | Colon Cancer | Cancer | 1 | null | null | 26 | 50,669 | 19,166.1562 | 23,070.0469 | 29 | white | 26.5 | 26 | 0.534912 | 0.211975 | 1 | 0 | 0 | metastatic | 1 | 0.65 | no dnr | 12 | 71 | null | 82 | 20 | 36 | 278.25 | null | null | 1 | 131 | 7.449219 | null | 18 | 4,875 | null | null | null | 3.33252 |
1,362 | 71.49097 | 1 | male | 0 | 13 | 146 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 44 | 136,072 | 23,399.875 | 29,611.5938 | 32.5 | black | 30.699219 | 39 | 0.344971 | 0.227997 | 12 | 0 | 0 | no | 0.2 | 0.2 | no dnr | 13 | 75 | 22.597656 | 75 | 11 | 38.59375 | 455 | null | null | 0.599976 | 142 | 7.55957 | 150 | 15 | 840 | null | null | null | 3.057617 |
1,363 | 45.19598 | 1 | male | 0 | 27 | 169 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | null | null | 26 | 481,895 | 84,690.4375 | 85,551.75 | 34.25 | white | 28.199219 | 49 | 0.649902 | 0.550903 | 29 | 0 | 0 | no | 0.6 | 0.6 | no dnr | 27 | 62 | 2.199707 | 115 | 56 | 36.19531 | 193.875 | null | 2.599609 | 0.799927 | 134 | 7.439453 | 171 | 12 | 8,210 | null | null | null | 2.964844 |
1,364 | 28.627 | 0 | male | 0 | 8 | 583 | CHF | COPD/CHF/Cirrhosis | 2 | 10 | under $11k | 0 | 30,279 | 16,035.2812 | 14,558.2891 | 17.5 | hispanic | 30.398438 | 29 | 0.855957 | 0.762939 | 1 | 0 | 0 | no | 0.5 | 0.5 | no dnr | 8 | 85 | 15.298828 | 120 | 14 | 38.59375 | null | null | null | 0.899902 | 137 | null | 136 | 12 | 850 | 0 | 0 | null | 0 |
1,365 | 54.14099 | 1 | male | 0 | 5 | 64 | Cirrhosis | COPD/CHF/Cirrhosis | 5 | null | null | 0 | 13,221 | 6,602.8633 | 6,746.19922 | 16 | white | 21.699219 | 37 | 0.796997 | 0.67395 | 1 | 0 | 0 | no | 0.8 | 0.8 | no dnr | 5 | 98 | 17.097656 | 135 | 39 | 36.5 | 225.6875 | null | null | 1 | 130 | 7.389648 | 224 | 23 | 2,487 | null | null | null | 3.075684 |
1,366 | 46.04199 | 1 | female | 0 | 6 | 449 | Colon Cancer | Cancer | 1 | null | null | 0 | 15,981 | 6,897.0938 | 6,455.27734 | 11 | white | 17.5 | 12 | 0.842896 | 0.655884 | 1 | 0 | 0 | metastatic | 0.7 | 0.6 | no dnr | 6 | 51 | null | 95 | 20 | 35.89844 | null | null | null | 1.699951 | 128 | null | null | 27 | 2,750 | null | null | null | 1.983887 |
1,367 | 71.19495 | 0 | female | 0 | 12 | 580 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 12 | null | 0 | 141,913 | 24,841.4375 | 23,073.8125 | 13 | white | 30.699219 | 47 | 0.46698 | 0.347961 | 28 | 0 | 0 | yes | 0.5 | 0.3 | dnr before sadm | -27 | 72 | 14.099609 | 125 | 32 | 37.89844 | 183.65625 | 3.299805 | null | 1.399902 | 140 | 7.169922 | 196 | 13 | 2,140 | 0 | 0 | no(M2 and SIP pres) | 0 |
1,368 | 60.25998 | 1 | female | 0 | 7 | 525 | Lung Cancer | Cancer | 1 | null | null | 0 | 23,886 | 11,874.4375 | 10,298.6094 | 6.5 | white | 21 | 20 | 0.634888 | 0.323975 | 1 | 0 | 0 | metastatic | 1 | 1 | no dnr | 7 | 50 | 7.199219 | 75 | 8 | 36.39844 | 187.5 | null | null | 3.399902 | 149 | 7.529297 | 138 | 93 | 2,970 | null | null | null | 3.341797 |
1,369 | 68.68695 | 1 | male | 0 | 5 | 257 | CHF | COPD/CHF/Cirrhosis | 2 | 12 | >$50k | 0 | 7,975 | 4,697.3516 | 4,011.48828 | 12 | white | 15.5 | 19 | 0.893921 | 0.821899 | 1 | 0 | 0 | no | 0.6 | 0.6 | no dnr | 5 | 113 | 11.5 | 110 | 32 | 36.69531 | 176 | 2.299805 | 2.099609 | 1.5 | 132 | 7.449219 | 173 | 23 | 3,785 | 0 | null | no(M2 and SIP pres) | 0.494751 |
1,370 | 58.741 | 1 | male | 0 | 9 | 172 | CHF | COPD/CHF/Cirrhosis | 2 | 8 | null | 0 | 33,382 | 15,641.9766 | 17,240.6719 | 26.5 | white | 20.097656 | 27 | 0.87793 | 0.795898 | 1 | 0 | 0 | no | 0.9 | 0.7 | no dnr | 9 | 47 | 8.199219 | 105 | 20 | 35.79688 | null | 3.799805 | 2.699707 | 1.299805 | 130 | null | 112 | 17 | 3,650 | 3 | 4 | null | 4 |
1,371 | 71.89294 | 0 | male | 0 | 4 | 578 | CHF | COPD/CHF/Cirrhosis | 2 | 31 | >$50k | 0 | 4,750 | 2,242.2637 | 3,116.61914 | 8 | white | 17.398438 | 22 | 0.868896 | 0.781982 | 1 | 0 | 0 | no | 1 | 0.9 | no dnr | 4 | 83 | 8 | 80 | 16 | 37 | null | 2.899902 | 8.898438 | 1.299805 | 132 | null | null | 21 | 760 | null | null | no(M2 and SIP pres) | 2.151856 |
1,372 | 62.34399 | 0 | male | 0 | 17 | 577 | CHF | COPD/CHF/Cirrhosis | 3 | 14 | $25-$50k | 0 | 145,561 | 81,578.1875 | 66,213.625 | 24.666656 | white | 25.597656 | 37 | 0.754883 | 0.611938 | 1 | 0 | 0 | yes | 0.75 | 0.7 | no dnr | 17 | 93 | 6.599609 | 126 | 24 | 38.39844 | null | null | 0.799927 | 0.899902 | 140 | null | 113 | 9 | 3,975 | 0 | 0 | no(M2 and SIP pres) | 0 |
1,373 | 60.66299 | 1 | female | 1 | 9 | 9 | MOSF w/Malig | ARF/MOSF | 2 | null | null | 41 | 233,830 | 57,363.3438 | 61,455.9375 | 52 | white | 53.59375 | 97 | 0 | 0 | 17 | 0 | 0 | yes | 0.1 | 0.1 | dnr after sadm | 5 | 100 | 0.899902 | 110 | 24 | 36.19531 | 218.34375 | null | null | 0.899902 | 130 | 7.529297 | null | 17 | 3,800 | null | null | <2 mo. follow-up | 2.802246 |
1,374 | 50.40097 | 0 | male | 0 | 7 | 576 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 9 | null | 0 | 81,871 | 11,551.2188 | 12,517.5859 | 15.5 | other | 16.699219 | 20 | 0.903931 | 0.868896 | 3 | 0 | 0 | no | 0.95 | 0.9 | no dnr | 7 | 77 | 12.099609 | 114 | 24 | 36 | null | null | null | null | 140 | null | null | null | 1,550 | null | null | null | 1.853027 |
1,375 | 51.52399 | 1 | female | 0 | 8 | 17 | Lung Cancer | Cancer | 1 | 14 | null | 0 | 21,235 | 9,458.8828 | 10,376.3281 | 18.5 | white | 22.5 | 28 | 0.622925 | 0.30896 | 1 | 0 | 0 | metastatic | 0 | 0 | dnr before sadm | -1 | 72 | null | 75 | 16 | 36.5 | null | null | null | 1.5 | 142 | null | null | 26 | 3,855 | null | null | <2 mo. follow-up | 3.532715 |
1,376 | 52.71698 | 1 | male | 1 | 8 | 8 | Coma | Coma | 1 | 20 | >$50k | 44 | 75,660 | 27,551.9062 | 27,582.4375 | 33 | black | 26.296875 | 46 | 0.521973 | 0.450989 | 2 | 1 | 0 | no | 0.5 | 0.5 | dnr after sadm | 8 | 50 | 6.199219 | 75 | 20 | 36.79688 | null | null | null | 1.199951 | 137 | null | null | 35 | 3,185 | null | 0 | <2 mo. follow-up | 0 |
1,377 | 64.64899 | 1 | female | 0 | 10 | 392 | Lung Cancer | Cancer | 1 | 12 | $11-$25k | 0 | 29,507 | 15,344.5391 | 13,907.7734 | 12 | white | 12.298828 | 15 | 0.789917 | 0.557983 | 1 | 0 | 0 | metastatic | 1 | 1 | no dnr | 10 | 73 | 8.099609 | 70 | 20 | 36 | null | null | null | 1.599854 | 141 | null | null | 30 | 3,300 | null | null | no(M2 and SIP pres) | 2.89502 |
1,378 | 73.51996 | 1 | female | 0 | 8 | 291 | Colon Cancer | Cancer | 2 | null | null | 0 | 13,121 | 6,902.6875 | 7,288.84766 | 13.5 | white | 14.898438 | 18 | 0.828979 | 0.628906 | 1 | 0 | 0 | metastatic | null | null | no dnr | 8 | 68 | 35.898438 | 120 | 28 | 36 | null | null | null | 1.199951 | 136 | null | null | 21 | 2,790 | null | null | null | 2.86084 |
1,379 | 63.685 | 1 | female | 1 | 20 | 20 | Coma | Coma | 3 | 11 | $11-$25k | 100 | 207,959 | 77,106.6875 | 86,680.125 | 30.666656 | white | 36.796875 | 66 | 0.003 | 0.001 | 2 | 0 | 0 | yes | 0.3 | 0.2 | dnr after sadm | 18 | 52 | 0.049995 | 105 | 10 | 35.69531 | 131 | null | 15.099609 | 3.099609 | 142 | 7.239258 | 326 | 32 | 0 | null | 3 | <2 mo. follow-up | 3 |
1,380 | 66.33295 | 1 | male | 0 | 118 | 181 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 14 | under $11k | 26 | 933,220 | 373,073 | 355,017.75 | 47.25 | white | 25.796875 | 53 | 0.656982 | 0.55896 | 3 | 0 | 0 | no | 0.5 | 0.5 | no dnr | 118 | 62 | 7.799805 | 100 | 36 | 38.29688 | 315 | null | null | 0.799927 | 136 | 7.449219 | null | 13 | 2,430 | null | 0 | adl>=4 (>=5 if sur) | 0 |
1,381 | 38.76498 | 1 | male | 0 | 10 | 202 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | $11-$25k | 37 | 143,626 | 54,987.5312 | 60,904.0938 | 50 | white | 26.699219 | 36 | 0.760986 | 0.684937 | 1 | 0 | 0 | no | 0.9 | 0.9 | no dnr | 10 | 61 | 5.5 | 116 | 12 | 36.19531 | null | null | null | 0.699951 | 143 | null | null | 9 | 1,550 | null | 0 | null | 0 |
1,382 | 65.55798 | 1 | male | 0 | 6 | 540 | Cirrhosis | COPD/CHF/Cirrhosis | 3 | 21 | $11-$25k | 0 | 9,123 | 4,302.4062 | 5,463.01953 | 10 | white | 19.296875 | 34 | 0.768921 | 0.632935 | 1 | 1 | 0 | no | 1 | 0.9 | no dnr | 6 | 122 | 110 | 55 | 14 | 38.69531 | 165 | null | null | 2 | 143 | 7.469727 | 281 | 25 | 2,380 | 0 | null | no(M2 and SIP pres) | 0.494751 |
1,383 | 46.56 | 1 | female | 1 | 10 | 10 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 12 | >$50k | 41 | 149,633 | 33,083.8438 | 36,292.4375 | 46.5 | white | 47.195313 | 85 | 0.100998 | 0.042 | 8 | 0 | 0 | no | 0.2 | 0.1 | dnr after sadm | 6 | 72 | 6.199219 | 76 | 20 | 37.79688 | null | null | null | null | 140 | null | null | null | 1,850 | null | 2 | <2 mo. follow-up | 2 |
1,384 | 67.89294 | 1 | female | 0 | 20 | 279 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | 12 | $25-$50k | 44 | 269,491 | 54,600.3438 | 57,670.75 | 42.666657 | white | 22.296875 | 37 | 0.634888 | 0.532959 | 5 | 0 | 0 | no | 0.8 | 0.7 | no dnr | 20 | 76 | 9.398438 | 72 | 20 | 36 | null | null | 0.399963 | 1.099854 | 141 | null | null | 18 | 1,400 | null | 0 | no(M2 and SIP pres) | 0 |
1,385 | 58.24197 | 1 | male | 0 | 6 | 88 | Colon Cancer | Cancer | 2 | 12 | $11-$25k | 0 | 11,848 | 5,331.1211 | 5,571.59766 | 9 | white | 45.695313 | 29 | 0.145996 | 0.008999 | 1 | 0 | 0 | metastatic | 0 | 0 | dnr after sadm | 1 | 92 | 3.399902 | 105 | 26 | 36 | null | 1.5 | 17 | 2.099609 | 126 | null | 84 | 66 | 875 | null | null | adl>=4 (>=5 if sur) | 2.475098 |
1,386 | 68.65997 | 0 | male | 0 | 4 | 567 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | null | null | 0 | 71,707 | 10,469.6094 | 13,937.4844 | 40 | white | 24.898438 | 25 | 0.753906 | 0.675903 | 3 | 0 | 0 | no | 0.9 | 0.9 | no dnr | 4 | 60 | 25.199219 | 105 | 28 | 38 | 332.5 | null | null | 3.199707 | 142 | 7.489258 | 212 | 49 | 585 | null | 0 | null | 0 |
1,387 | 53.49197 | 1 | female | 0 | 13 | 15 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 4 | under $11k | 41 | 199,060 | 58,617.875 | 60,350.5625 | 42.5 | hispanic | 39.195313 | 71 | 0.346985 | 0.230988 | 1 | 0 | 0 | no | 0.1 | 0.05 | no dnr | 13 | 65 | 9.398438 | 95 | 6 | 36.29688 | 455 | null | 6.899414 | 1.899902 | 149 | 7.539062 | 73 | 53 | 2,945 | null | 5 | <2 mo. follow-up | 5 |
1,388 | 70.71295 | 0 | female | 0 | 10 | 563 | Colon Cancer | Cancer | 1 | null | null | 0 | 35,262 | 15,618.2266 | 18,277.7969 | 17 | white | 11.798828 | 15 | 0.86792 | 0.703979 | 1 | 0 | 0 | metastatic | 1 | 0.95 | no dnr | 10 | 77 | 4.799805 | 78 | 20 | 35.69531 | null | 3.899902 | 3 | 1.5 | 138 | null | 111 | 31 | 1,825 | null | null | null | 2.425781 |
1,389 | 68.73895 | 1 | male | 1 | 4 | 4 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 16 | $25-$50k | 41 | 58,336 | 22,046.9688 | 23,853.125 | 39 | white | 44.898438 | 101 | 0.085999 | 0.032997 | 2 | 1 | 0 | no | 0.05 | 0.05 | dnr after sadm | 4 | 52 | 6.599609 | 115 | 40 | 38.59375 | 270 | null | 46 | 3.699707 | 143 | 7.449219 | 340 | 95 | 424 | null | null | <2 mo. follow-up | 2.916016 |
1,390 | 60.87097 | 1 | male | 0 | 5 | 187 | Colon Cancer | Cancer | 3 | null | null | 0 | 11,670 | 4,700.5703 | 5,847.15625 | 18 | white | 16.199219 | 17 | 0.833984 | 0.637939 | 1 | 1 | 0 | metastatic | 0.9 | 0.2 | no dnr | 5 | 65 | 6.599609 | 75 | 8 | 38 | null | 3.299805 | 3 | 3.5 | 135 | null | 106 | 101 | 3,360 | null | null | null | 3.194336 |
1,391 | 77.14398 | 0 | male | 0 | 24 | 560 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | $25-$50k | 9 | 328,863 | 67,441.9375 | 68,026.9375 | 27.333328 | white | 35.695313 | 80 | 0.362 | 0.244995 | 1 | 1 | 0 | yes | 0.5 | 0.5 | no dnr | 24 | 74 | 9.099609 | 110 | 18 | 36 | null | 2 | 0.299988 | 0.699951 | 120 | null | 84 | 8 | 900 | null | 0 | adl>=4 (>=5 if sur) | 0 |
1,392 | 61.92999 | 0 | male | 0 | 6 | 559 | Cirrhosis | COPD/CHF/Cirrhosis | 5 | 8 | under $11k | 0 | 7,500 | 3,849.8496 | 4,052.82812 | 11 | hispanic | 19 | 23 | 0.795898 | 0.671997 | 1 | 1 | 0 | no | 0.5 | 0 | no dnr | 6 | 72 | 8.099609 | 55 | 20 | 36.19531 | 91.65625 | null | 0.599976 | 1.399902 | 138 | 7.419922 | null | 26 | 1,636 | 0 | null | no(M2 and SIP pres) | 0.494751 |
1,393 | 43.05798 | 0 | female | 0 | 15 | 555 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 16 | >$50k | 0 | 94,436 | 28,478.7031 | 27,283.9844 | 15.666664 | white | 22.398438 | 19 | 0.85498 | 0.804932 | 7 | 0 | 0 | no | 0.5 | 0.1 | no dnr | 15 | 70 | 26.097656 | 110 | 28 | 35.5 | 302.5 | null | 22.597656 | 2.199707 | 133 | 7.349609 | 223 | 77 | 1,885 | null | null | no(M2 and SIP pres) | 2.992676 |
1,394 | 54.47998 | 1 | male | 0 | 6 | 104 | MOSF w/Malig | ARF/MOSF | 1 | null | null | 0 | 19,860 | 8,709 | 8,849.10938 | 14 | white | 23.296875 | 16 | 0.664917 | 0.567993 | 1 | 1 | 0 | metastatic | 0.05 | 0.01 | no dnr | 6 | 65 | 8.599609 | 75 | 24 | 38.09375 | null | null | 0.5 | 1.199951 | 138 | null | 95 | 18 | 4,085 | 0 | null | null | 0.494751 |
1,395 | 80.323 | 1 | female | 0 | 12 | 49 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | null | null | 26 | 51,079 | 21,268.8438 | 20,973.2188 | 32.5 | white | 27.398438 | 70 | 0.574951 | 0.464966 | 1 | 1 | 1 | no | 0.7 | 0.5 | dnr after sadm | 3 | 99 | 7 | 79 | 28 | 36.39844 | 252.375 | null | null | 0.799927 | 137 | 7.449219 | 95 | 15 | 1,925 | null | null | <2 mo. follow-up | 6.46582 |
1,396 | 32.28198 | 1 | male | 1 | 13 | 13 | MOSF w/Malig | ARF/MOSF | 1 | 13 | under $11k | 44 | 226,262 | 59,380.7188 | 61,909.5 | 41.5 | hispanic | 29 | 49 | 0.314941 | 0.201996 | 13 | 0 | 0 | yes | 0.5 | 0.3 | dnr after sadm | 11 | 52 | 28.398438 | 70 | 34 | 35.79688 | 184 | 2.299805 | 27.699219 | 4.5 | 145 | 7.449219 | 207 | 66 | 35 | null | 0 | <2 mo. follow-up | 0 |
1,397 | 44.73099 | 1 | male | 1 | 38 | 38 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 18 | null | 0 | 800,959 | 216,988.875 | 202,004 | 48.25 | white | 29.398438 | 43 | 0.717896 | 0.631958 | 50 | 0 | 0 | no | 0.5 | 0.5 | dnr after sadm | 33 | 109 | 6.199219 | 85 | 28 | 36.59375 | 313.3125 | null | null | 1 | 134 | 7.459961 | 154 | 16 | 3,350 | null | 0 | <2 mo. follow-up | 0 |
1,398 | 49.44598 | 1 | male | 0 | 5 | 8 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | null | null | 61 | 53,642 | 24,402.3594 | 24,352.9531 | 53 | hispanic | 41 | 93 | 0.144989 | 0.068985 | 1 | 0 | 0 | yes | null | null | dnr before sadm | 0 | 60 | 29 | 120 | 24 | 36 | 120 | null | 3.099609 | 8.5 | 142 | 7.429688 | 146 | 89 | 55 | null | null | <2 mo. follow-up | 4.116211 |
1,399 | 68.07098 | 0 | male | 0 | 12 | 547 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 6 | $11-$25k | 9 | 96,931 | 27,934.3906 | 26,548.6562 | 27 | white | 28.199219 | 39 | 0.589966 | 0.480957 | 3 | 0 | 0 | yes | 0.9 | 0.9 | no dnr | 12 | 71 | 4.699219 | 78 | 20 | 36.79688 | null | null | 1.599854 | 1.199951 | 127 | null | 282 | 30 | 2,100 | null | null | null | 2.520996 |
1,400 | 61.71899 | 0 | male | 0 | 28 | 543 | CHF | COPD/CHF/Cirrhosis | 3 | null | null | 0 | 205,874 | 110,087.375 | 88,449.4375 | 27.5 | white | 21.296875 | 36 | 0.85791 | 0.764893 | 1 | 1 | 0 | no | 0.92 | 0.85 | no dnr | 28 | 75 | 20.898438 | 104 | 30 | 38.59375 | 173.3125 | null | 1.099854 | null | 138 | 7.479492 | null | null | 2,050 | 1 | null | null | 1.166748 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.